desipramine has been researched along with Arthritis, Degenerative in 1 studies
Desipramine: A tricyclic dibenzazepine compound that potentiates neurotransmission. Desipramine selectively blocks reuptake of norepinephrine from the neural synapse, and also appears to impair serotonin transport. This compound also possesses minor anticholinergic activity, through its affinity to muscarinic receptors.
desipramine : A dibenzoazepine consisting of 10,11-dihydro-5H-dibenzo[b,f]azepine substituted on nitrogen with a 3-(methylamino)propyl group.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Altenbach, RJ | 1 |
Black, LA | 1 |
Strakhova, MI | 1 |
Manelli, AM | 1 |
Carr, TL | 1 |
Marsh, KC | 1 |
Wetter, JM | 1 |
Wensink, EJ | 1 |
Hsieh, GC | 1 |
Honore, P | 1 |
Garrison, TR | 1 |
Brioni, JD | 1 |
Cowart, MD | 1 |
1 other study available for desipramine and Arthritis, Degenerative
Article | Year |
---|---|
Diaryldiamines with dual inhibition of the histamine H(3) receptor and the norepinephrine transporter and the efficacy of 4-(3-(methylamino)-1-phenylpropyl)-6-(2-(pyrrolidin-1-yl)ethoxy)naphthalen-1-ol in pain.
Topics: Animals; Histamine H3 Antagonists; Naphthols; Norepinephrine Plasma Membrane Transport Proteins; Ost | 2010 |